» Articles » PMID: 37165619

Plumbing Mysterious RNAs in "dark Genome" for the Conquest of Human Diseases

Overview
Journal Mol Ther
Publisher Cell Press
Date 2023 May 11
PMID 37165619
Authors
Affiliations
Soon will be listed here.
Abstract

Next-generation sequencing has revealed that less than 2% of transcribed genes are translated into proteins, with a large portion transcribed into noncoding RNAs (ncRNAs). Among these, long noncoding RNAs (lncRNAs) represent the largest group and are pervasively transcribed throughout the genome. Dysfunctions in lncRNAs have been found in various diseases, highlighting their potential as therapeutic, diagnostic, and prognostic targets. However, challenges, such as unknown molecular mechanisms and nonspecific immune responses, and issues of drug specificity and delivery present obstacles in translating lncRNAs into clinical applications. In this review, we summarize recent publications that have explored lncRNA functions in human diseases. We also discuss challenges and future directions for developing lncRNA treatments, aiming to bridge the gap between functional studies and clinical potential and inspire further exploration in the field.

Citing Articles

Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives.

Xu S, Chen T, Yu J, Wan L, Zhang J, Chen J Mol Ther Nucleic Acids. 2024; 35(3):102281.

PMID: 39188306 PMC: 11345382. DOI: 10.1016/j.omtn.2024.102281.


LncRNAs: Current understanding, future directions, and challenges.

Liang X, Wang X Animal Model Exp Med. 2023; 6(6):505-507.

PMID: 38146076 PMC: 10757209. DOI: 10.1002/ame2.12371.


Macrophage-mediated downregulation of lncRNA Carmn in mouse abdominal aortic aneurysm.

Yang H, Zhou T, Liu B Vascul Pharmacol. 2023; 154:107264.

PMID: 38097098 PMC: 10939852. DOI: 10.1016/j.vph.2023.107264.


[High expression of long noncoding RNA UCA1 promotes invasion, migration and epithelial-mesenchymal transition of trophoblasts ].

Sun J, Zhang Y, Yang L, Zhou L, Lu X, Li J Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(11):1984-1988.

PMID: 38081619 PMC: 10713461. DOI: 10.12122/j.issn.1673-4254.2023.11.21.


Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway.

Bu T, Li L, Tian J Front Pharmacol. 2023; 14:1269233.

PMID: 37829301 PMC: 10565042. DOI: 10.3389/fphar.2023.1269233.


References
1.
Rinaldi C, Wood M . Antisense oligonucleotides: the next frontier for treatment of neurological disorders. Nat Rev Neurol. 2017; 14(1):9-21. DOI: 10.1038/nrneurol.2017.148. View

2.
Kindgren P, Ard R, Ivanov M, Marquardt S . Transcriptional read-through of the long non-coding RNA SVALKA governs plant cold acclimation. Nat Commun. 2018; 9(1):4561. PMC: 6212407. DOI: 10.1038/s41467-018-07010-6. View

3.
Pan Y, Zhang Y, Jia T, Zhang K, Li J, Wang L . Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles. FEBS J. 2012; 279(7):1198-208. DOI: 10.1111/j.1742-4658.2012.08512.x. View

4.
Guevara N, Kim H, Antonova E, Chan L . The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med. 1999; 5(3):335-9. DOI: 10.1038/6585. View

5.
Vausort M, Wagner D, Devaux Y . Long noncoding RNAs in patients with acute myocardial infarction. Circ Res. 2014; 115(7):668-77. DOI: 10.1161/CIRCRESAHA.115.303836. View